Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Adocia ACT (OTC: ADOCY).

Full DD Report for ADOCY

You must become a subscriber to view this report.


Recent News from (OTC: ADOCY)

Adocia ACT ADR reports 1H results
Adocia ACT ADR ( OTCPK:ADOCY ): 1H net income of €10.64M Revenue of €32.8M (+68.5% Y/Y) Press Release More news on: Adocia ACT ADR, Adocia ACT, Earnings news and commentary, ,
Source: SeekingAlpha
Date: July, 18 2018 12:13
Week In Review: Fosun In $2 Billion Bidding War For U.S. Rights To Novartis' Generic Drugs
Deals and Financings Fosun Pharma (SHA: 600196; HK: 02196) is one of the finalists in a $2 billion bidding war to acquire part of Novartis' (NVS) US portfolio of generic drugs. Novartis is auctioning off US rights to lower-margined members of its Sandoz generic portfolio while it keeps the...
Source: SeekingAlpha
Date: May, 20 2018 07:55

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-14N/A13.00N/AN/A0
2018-12-13N/A13.00N/AN/A0
2018-12-12N/A13.00N/AN/A0
2018-12-1113.0013.0013.0013.00300
2018-12-10N/A19.70N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-09-24500500100.0000Short
2018-09-19100100100.0000Short
2018-09-1450070071.4286Short
2018-09-13200200100.0000Short
2018-09-12100100100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ADOCY.


About Adocia ACT (OTC: ADOCY)

Logo for Adocia ACT (OTC: ADOCY)

ADOCIA is a biotechnology company specialized in the development of best in class medicines from already approved therapeutic agents

 

Contact Information

 

 

Current Share Structure

     



    Daily Technical Chart for (OTC: ADOCY)

    Daily Technical Chart for (OTC: ADOCY)


    Stay tuned for daily updates and more on (OTC: ADOCY)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (OTC: ADOCY)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ADOCY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ADOCY and does not buy, sell, or trade any shares of ADOCY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/